Probing the partly folded states of proteins by limited proteolysis
Rather, it is a normal part of chronic disease management
Dr Paul Yates, a consultant geriatrician and deputy director of aged care research at Austin Health, Australia, is among those working in the area
For some, the mental boost of ALCAR is a game-changer
In the fight against discrimination, as in the fight against obesity, we are in uncharted territory, the former FDA commissioner David Kessler writes about GLP-1 access in a recent book titled Diet, Drugs and Dopamine. One big exception to the coverage denial trend: For seniors, Medicare this month launched a pilot program that covers weight-loss drugs for just a $50 monthly copay
The honest answer is more nuanced than either side of that conversation